Organization | University of Aberdeen

University of Aberdeen Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Aberdeen United Kingdom (1495)

Organization Overview

First Clinical Trial

2001

NCT02015260

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Aberdeen Royal Infirmary, Foresterhill, Aberdeen, AB25 2ZN, United Kingdom | Aberdeen Royal Infirmary UK | NHSGRAMPIAM | NHS Grampian | Rosa Moreno Lopez | Rowett Institute of Nutrition and Health, University of Aberdeen | Rowett Institute of Nutrition and Health, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom | Rowett Institute of Nutrition and Health, University of Aberdeen, Scotland, UK | Rowett Institute, University of Aberdeen | The Rowett Institute, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD | Univeristy of Aberdeen | University of Aberdeen | University of Aberdeen & NHS Grampian | University of Aberdeen Rowett Institute of Nutrition and Health | University of Aberdeen, The Rowett Institute | Univetsity of Aberdeen | UoA Rowett Institute of Nutrition and Health

Active Ingredients

Drugs in Phase 4 Trials (18)

acetylcysteine (mucomyst) (1 trial)

adalimumab (humira) (1 trial)

azithromycin (zithromax) (1 trial)

cephalexin (keflex) (1 trial)

chlorhexidine (hibitane) (1 trial)

etanercept (enbrel) (1 trial)

fenofibrate (fenoglide) (1 trial)

isotretinoin (Accutane) (1 trial)

ketamine (ketalar) (1 trial)

nitrofurantoin (furadantin) (1 trial)

nitroglycerin (transderm-nitro) (1 trial)

ondansetron (zofran) (1 trial)

propofol (diprivan) (1 trial)

rituximab (rituxan) (1 trial)

sea water (1 trial)

sodium chloride (2 trials)

thymol (1 trial)

trimethoprim (1 trial)

Drugs in Phase 3 Trials (8)

conjugated linoleic acid (1 trial)

cyclophosphamide (cytoxan) (1 trial)

egf-rp64k (1 trial)

egf vaccine (1 trial)

mannitol (Osmitrol) (1 trial)

montanide isa51 (1 trial)

montelukast (singulair) (1 trial)

sodium nitrite (2 trials)

Drugs in Phase 2 Trials (7)

cysteamine (cystagon) (1 trial)

melatonin (2 trials)

nitrous oxide (1 trial)

perhexiline (1 trial)

sodium nitrate (1 trial)

tacrolimus (prograf) (1 trial)

Drugs in Phase 1 Trials (1)

selumetinib (Koselugo) (1 trial)

Drugs in Other Trials (39)

arabinoxylan (1 trial)

arginine (1 trial)

beetroot juice (1 trial)

berry polyphenols (1 trial)

beta-glucans (1 trial)

bilberry (1 trial)

black currant (1 trial)

brazil nut (1 trial)

cherry (1 trial)

cocoa bean (1 trial)

dark chocolate (1 trial)

fava beans (1 trial)

fermented maillard reacted whey protein (1 trial)

fiber (1 trial)

fish oil (Omegavan) (1 trial)

garlic (1 trial)

green currants (1 trial)

honeyberry (1 trial)

inulin (1 trial)

ivabradine (corlanor) (1 trial)

lecithin (1 trial)

maltodextrin (1 trial)

molkosan (2 trials)

mussel (1 trial)

prulifloxacin (1 trial)

psyllium (1 trial)

raspberry (1 trial)

ropivacaine (naropin) (1 trial)

salmon (1 trial)

vitamin c (2 trials)

vitamin e (1 trial)

wheat (1 trial)

whey protein (2 trials)

zinc sulfate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acne Vulgaris (Phase 4)

Angina Pectoris (Phase 2)

Angina, Stable (Phase 2)

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Asthma (Phase 2)

Atherosclerosis (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Condylomata Acuminata (Phase 2)

Crohn Disease (Phase 2)

Cystic Fibrosis (Phase 2)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Diabetic Retinopathy (Phase 4)

Fibrosis (Phase 2)

Heart Failure (Phase 2)

Heart Failure, Diastolic (Phase 2)

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Periodontal Diseases (Phase 4)

Placenta, Retained (Phase 4)

Poisoning (Phase 4)

Respiratory Sounds (Phase 3)

Retinal Diseases (Phase 4)

Sepsis (Phase 2)

ST Elevation Myocardial Infarction (Phase 3)

Toxemia (Phase 2)

Urinary Tract Infections (Phase 4)

Warts (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 52
# of Trial APIs: 73